SYNCHRO PHARMACEUTICALS
Pharmaceutical company · 41 brands · 50 molecules
Ranked #6 of 156 companies in Antianemic, Iron Preparations
Company overview
SYNCHRO PHARMACEUTICALS is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 41 product registrations across 50 distinct molecules. Its portfolio is concentrated in Antianemic, Iron Preparations and Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord). DRAP has issued 1 alert involving its products.
Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.
Top molecules by brand count
Therapeutic classes
Regulatory record
1 alert in the DRAP feed we track.
Competitive set
Companies whose registered portfolio overlaps most with this one.
Get the full profile for SYNCHRO
This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.
Request this brief See what’s included